$17m contract win for production inspection systems
Kromek announced today that it had been awarded a 7 year $17m contract with a large US OEM to supply next generation CZT detectors to identify contaminants within production processes for quality inspection purposes. The order relates to a $660k development agreement, which was announced on 2nd November 2020.We think this is a significant achievement on numerous fronts. Not least because it’s a marvellous endorsement & statement of intent from another leading corporation. Alongside materially increasing Kromek’s orderbook and derisking our conservative forecasts, whilst equally enabling the firm to generate long term, high margin revenues across the lifetime of this platform.
We believe Kromek is emerging from the pandemic in fine fettle. Not only demonstrating once again the versatility of its state-of-the-art products across numerous high margin applications within the multi-$bn medical, nuclear, security and now industrial sectors. But also providing the group with a host of exciting ‘shots on goal’ via its well funded (£7.4m Apr’21) commercialisation strategy.
Kromek Group is a developer of radiation detectors based on cadmium zinc telluride, providing detection and characterization capabilities within the medical imaging, nuclear detection and security screening markets. Co. designs, develops and produces x-ray and gamma-ray imaging and radiation detection products.
Equity Development enables companies to become better understood and supported by investors. Since our launch in 1996 we have consistently focused on helping our clients improve their communication and relationships with both existing and potential shareholders. Our clients have come from a wide variety of sectors and domiciles, are both private and quoted and range in size from micro-cap to $multi-billions. We offer free access to company research notes written by experienced analysts. These notes include detailed forecasts, financial models and a fair value. We host regular Private Investor Forums at which investors have the opportunity to hear company directors present, and to ask questions. These are free to attend. We broadcast live Webinars with company management that include active Q&A. We also make the recordings available online. We arrange face to face meetings between private investors and company management. We are active users of Twitter, commenting daily on company news, share price moves, Directors’ Dealings, Equity Development Research Notes & Events.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.